aTYR PHARMA INC 8-K

What Happened
aTyr Pharma, Inc. filed a Form 8-K on June 1, 2026 to disclose that it will use an investor presentation for meetings with investors, stockholders and analysts and at investor conferences. The presentation, dated June 2026, is attached as Exhibit 99.1 and the company plans to make the materials available on its website. The company stated it does not undertake to update the presentation.

Key Details

• Filing date: June 1, 2026 (Form 8-K, Item 7.01 Regulation FD Disclosure).
• Presentation attached as Exhibit 99.1, titled "Corporate Presentation Materials of aTyr Pharma, Inc. dated June 2026."
• Use: meetings with investors, stockholders and analysts and presentation at investor conferences; will be posted on the company website.
• Company disclaimer: does not intend to update the presentation materials after posting.

Why It Matters
This filing is a Regulation FD disclosure to ensure public access to the same investor presentation the company will use in outreach. For investors, it means the company’s messaging, strategy updates or program highlights included in the deck are now publicly available and can be reviewed alongside other public filings. The 8-K does not contain financial results or executive changes; it primarily documents disclosure of the presentation material (Exhibit 99.1).